Log In
Print this Print this

BTDS, Butrans, Norspan tape, buprenorphine

  Manage Alerts
Collapse Summary General Information
Company Purdue Pharma L.P.
DescriptionBuprenorphine transdermal system
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat moderate to severe chronic low back pain; Treat moderate to severe pain; Treat moderate to severe pain in patients requiring continuous, around-the-clock treatment with opioid medications
Regulatory Designation
PartnerHisamitsu Pharmaceutical Co. Inc.;
Mundipharma International Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today